Department of Pharmacy and Pharmacology

Professor Eddie French

Visting Professor

Director Biopharmaceutical Development ReMedDes


Tel: +44 (0) 7881 511800

Professor Eddie French


Eddie French is a visiting Professor in the Department of Pharmacy and Pharmacology and is associated with the Research in Medicines Design (ReMedDes) group. Eddie has a BSc in Biochemistry and a PhD in transdermal drug delivery, both from the University of Bath.

Professor French is currently an independent pharmaceutical sciences consultant to the pharmaceutical and biotech sectors specialising in drug product development. He was been contracted to the university on a part time basis for two years as the Director of Biopharmaceutical Development for the ReMedDes group. He was previously a lecturer at Bath in the Department of Pharmacy and Pharmacology, before taking a career change and joining the pharmaceutical industry.

He spent 17 years at the Pfizer Sandwich site, his time being split between leading the liquids formulation group, which included establishing Pfizer’s protein and peptide formulation capability, and as a director in the inhalation and devices group. He spent his last four years at Pfizer being the director of device enabled drug delivery, focussing on drug delivery systems for novel therapeutics and vaccines. During this time Eddie spent 9 months seconded to the STEM centre at the University of Nottingham as an EPSRC KT fellow focusing on drug delivery needs for tissue engineering and stem cells.

Eddie has previously been the Chair of the Academy of Pharmaceutical Sciences of Great Britain. In his time as chair he helped establish the APS UK Pharm Sci. conference. He has chaired several international drug delivery conferences and sits on several industrial and organisational advisory panels. 

Research Interests

Eddie has broad interests in the fields of drug delivery and the development of drug products. He has specialist knowledge in the formulation, development and characterisation of both parenteral and inhaled drug products.

He has worked extensively on the formulation and characterisation of drug products for biological molecules including proteins, notably monoclonal antibodies, peptides and oligonucleotides, via both the injectable and alternative non- invasive routes.

He has collaborated closely with device engineers and medical technology scientists to establish a strong background in device-based drug delivery and device development.